Citi Downgrades Ovid Therapeutics Inc (OVID) to Neutral
Tweet Send to a Friend
Citi analyst Yigal Nochomovitz downgraded Ovid Therapeutics Inc (NASDAQ: OVID) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
